Clinical Trials Logo

Clinical Trial Summary

This study aims to investigate the effects of an individually planned exercise program, counseling and family education on the followings in patients with hemophilia (PWH); 1. To examine the joint range of motion, muscle strength and functional status. 2. To evaluate the level of physical activity and daily living activities 3. To aim to determine the amount of change after participation.


Clinical Trial Description

Hemophilia is defined as bleeding in the musculoskeletal system and soft tissues as a result of the lack of clotting factors in the blood. Recurrent attacks of hemarthrosis cause pain, also because of the pain patients tend to use joints less than usual. The decrease in joint movement makes it harder to return to active movement again. There is a limited literature on the effects of exercise on children with hemophilia. Hemophilia is a hereditary bleeding disorder that develops as a result of factor VIII or IX deficiency; it is a rarely seen disease that discloses itself by hemarthrosis and intramuscular bleeding. Factor VIII deficiency is called Hemophilia A and Factor IX deficiency is called Hemophilia B. This disease is inherited by the X chromosome and passes on to male children through female carriers. Although Hemophilia A is observed rarely, one in about 5,000-10,000 male births, its frequency is still 5-6 times higher than Hemophilia B. Around 70% of hemophilia A patients have more severe disease, however, this rate is approximately 50% in hemophilia B. Hemophilia patients experience bleeding in the musculoskeletal system and soft tissues as a result of the lack of clotting factors in the blood. Recurrent attacks of hemarthrosis cause pain, also because of the pain patients tend to use joints less than usual. Decrease in joint movement makes it harder to return to active movement again in the majority of the cases, bleeding occurs into the joint (mostly the knee, elbow and ankle) and only a small part of the bleedings occurs into the muscle (especially the iliopsoas, calf and forearm muscles). In order to be able to participate according to the international classification of functions of health (ICF), it is prioritized that the activities are functional. Targeted treatment is a functional treatment application that conforms to ICF's "activities and participation among children. An activity is carrying out of a task or movement by an individual and the difficulties faced while carrying out the tasks or movements is called limitations. Participation means the individual's being in life. In life conditions, problems confronted are participation restrictions. Activity limitations can often lead to participation restrictions. Fear of bleeding in pediatric patients, particularly from the period of childbirth leads families to form an immobile lifestyle for their children compared to healthy individuals. The recurrent bleeding often occurs in the lower extremity joints, it causes pain and swelling, therefore patients need to keep the joint immobile which is particularly the reason why patients spend these periods mostly resting. So then, again, patients forfeit activity for fear of recurrent bleeding. The decrease in activity leads to a loss of strength and balance. Also, sports that could lead to bleeding or trauma are not suitable for hemophilia patients. The benefits and risks of sports activities for hemophilic individuals should be well known and the patient should be oriented toward suitable sports. For this reason the rehabilitation program should be arranged as a personalized and systematic program according to local and general joint and muscle conditions. Hematologic therapy alone is not sufficient for the treatment of musculoskeletal bleeding. The sedentary lifestyle that develops with hemophilic arthropathy often leads to immobility problems such as decreased muscle strength, weak balance and coordination, increased risk of obesity. These problems lead to instability and changes in joint loads, thereby instances of new bleeding and increased joint damages. In a similar way, after hemarthrosis, in acute situations, if the necessary period of resting is not accompanied by an appropriate physiotherapy, it causes a vicious cycle of immobility, new bleeding and eventually hemophilic arthropathy and loss of function. The key to the successful management of hemophilic arthropathy is to begin the treatment early. The first step of treatment for hemophilic arthropathy is physiotherapy with factor replacement to prevent bleeding attacks and joint damage before hemarthrosis progresses to chronic synovitis and joint erosion. Physical activity means body movement by using energy and exercise means planned physical activities that are personally structured. Regular exercise can prevent the progression of hemophilic arthropathy or it may reduce the risk. Therapeutic exercises are the main elements of rehabilitation for Patients with hemophilic arthropathy and muscle bleeding. The main objective of therapy should be the following: restoration or preservation of range of motion, strengthening of muscles, prevention or treatment of joint contracture, pain management, increasing exercise tolerance, improvement of balance, coordination, and proprioception. To prevent patients from giving up on exercising earlier than required, İt is important to assist patients, encourage them during exercises, support them and when necessary give them advice and explain the exercises in a way that patients can easily and clearly understand. There is a fine line between beneficial and harmful activities, this fine line leads many patients with bleeding disorder to avoid exercise for fear of causing bleeding. Paradoxically, when people with bleeding disorders avoid exercising this causes decreased function, range of motion, and quality of life because of muscle weakness. In Turkey, the cost of joint health complications in patients with hemophilia and other inherited bleeding disorders is significantly high however most significant point is that these costs can be avoided. Physical activity which is a non-pharmacologic treatment method, plays an important role in reducing the risks, alleviating the symptoms and improving the results in hemophilia. For this reason, it is very important to develop strategies to increase the level of physical activity. In the relevant literature there are very few studies on the effects of exercise in pediatric patients with hemophilia. With this study, we plan to show, in an objective manner, that the personally planned exercise program leads to change in the level of physical activity, activities of daily life and participation. The Methods of the Study Before the study the patients and their families will be informed about the evaluations, treatments that will be made. They will be also informed about outcomes and evaluations after the treatment, and the risks that they may face during the the treatments. They will also be asked to sign the "Informed Consent Form" for their voluntary participation in the study. An "Assessment Form" will be prepared in order to keep the record of demographic and disease information of all the cases included in the study. Hemophilia types, patients biographic information, family history, the time when the disease was diagnosed, treatments taken, medications used, body mass index, range of motion and muscle strength will be recorded in this assessment form. Randomly patients will be divided into two groups as physical activity counseling and individually planned exercise group and only physical activity counseling group. We plan that the exercise will be done for 50 minutes a day, twice in a week and will last for 8 weeks. Before and after the 8-week intervention program of all patients physical activity levels with International Physical Activity Questionnaire (IPAQ), activity performance exercise with Children's Functional Independence Scale (Wee-FIM) and Canadian Occupational Performance Measurement (COPM), joint health with hemophilia joint health scoring (HESS), exercise capacity with 6-minute walking test (6MWT) and sit-and-stand test, hand function speed and dexterity with Jebsen-Taylor Hand Function Test (JTHFT) and quality of life with Pediatric's Quality of life Scale (PedsQL) will be evaluated. Assessment methods, exercise and counseling practices will be carried out in the Turkey Hemophilia Society of Physiotherapy Unit.Only the participants in the hematologists follow-up will continue their routine doctor checks and recommendations. All analyzes will be performed using Statistical Package for Social Sciences (SPSS) for Windows 22. The compliance of the data to normal distribution will be evaluated by drawing the Kolmogorov-Smirnov test and histogram. Parametric tests will be used for data suitable for normal distribution. Data that are not suitable for normal distribution will be analyzed with non-parametric tests. Variables will be defined by their mean and standard deviation values. Analyzes and correlations between groups will be examined separately with appropriate tests. A value of p<0.05 will be considered statistically significant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04703062
Study type Interventional
Source Istanbul University-Cerrahpasa
Contact
Status Completed
Phase N/A
Start date February 20, 2020
Completion date March 20, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05617209 - In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients
Completed NCT05039008 - Restricting Blood Flow in Improving Muscle Strength in Patients With Hemophilic Arthropathy N/A
Recruiting NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Terminated NCT02586012 - Weight-based Dosing in Hemophilia A Phase 2
Unknown status NCT02165592 - Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia N/A
Completed NCT02546622 - ATHN 2: Factor Switching Study
Completed NCT02165462 - Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy N/A
Unknown status NCT02433782 - Myofascial Therapy in Patients With Hemophilic Arthropathy N/A
Completed NCT01232634 - Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and Ankles Phase 2
Completed NCT05104164 - Self-myofascial Release in Hemophilic Ankle Arthropathy N/A
Terminated NCT01191372 - First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients Phase 1
Completed NCT05173129 - Posture Analysis for Patients With Haemophilia N/A
Completed NCT03818529 - ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Withdrawn NCT03996486 - Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia Phase 1
Completed NCT01708564 - A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B Phase 1
Completed NCT03842605 - Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia N/A
Completed NCT05549843 - Manual Therapy in the Treatment of Hemophilic Arthropathy of the Ankle N/A
Recruiting NCT06010953 - SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment Phase 1/Phase 2
Completed NCT05027230 - A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor Phase 1/Phase 2
Not yet recruiting NCT06014320 - Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease